Eltrombopag, a thrombopoietin receptor agonist used to treat thrombocytopenia, has a reported IC50 8.3 μM for SARS-CoV-2 infection in Vero and Calu-3 cells (Ko et al., 2021). The gene discussed is MPL; the disease is Thrombocytopenia.